Cover Image
Market Research Report
Product code
1027168

AI-based Clinical Trials Solution Provider Market Research Report by Application, by End User, by Phase, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

Published: | 360iResearch LLP | 189 Pages | Delivery time: 1-2 business days

Price

Back to Top
AI-based Clinical Trials Solution Provider Market Research Report by Application, by End User, by Phase, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
Published: September 7, 2021
360iResearch LLP
Content info: 189 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The Global AI-based Clinical Trials Solution Provider Market size was estimated at USD 4,499.63 Million in 2020 and expected to reach USD 4,938.35 Million in 2021, at a Compound Annual Growth Rate (CAGR) 10.08% to reach USD 8,009.89 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the AI-based Clinical Trials Solution Provider to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Application, the AI-based Clinical Trials Solution Provider Market was studied across Cardiovascular Diseases, Infectious Diseases, Metabolic Diseases, Neurological Diseases or Conditions, and Oncology.
  • Based on End User, the AI-based Clinical Trials Solution Provider Market was studied across Academia, Others, and Pharmaceutical Companies.
  • Based on Phase, the AI-based Clinical Trials Solution Provider Market was studied across Phase-I, Phase-II, and Phase-III.
  • Based on Region, the AI-based Clinical Trials Solution Provider Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the AI-based Clinical Trials Solution Provider Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global AI-based Clinical Trials Solution Provider Market, including AiCure, LLC, Aiforia, Antidote Technologies, Inc., Avantor, Inc., Deep 6 AI, Deep Lens Inc., Innoplexus Consulting Services Pvt Ltd, Intelligencia.ai, MEDIAN Technologies, Mendel.ai, Pharmaceutical Pipeline Enhancement Strategies, LLC, Saama Technologies Pvt Ltd, Simplifai AS, Trials.ai, and Unlearn.AI, Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global AI-based Clinical Trials Solution Provider Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global AI-based Clinical Trials Solution Provider Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global AI-based Clinical Trials Solution Provider Market?
  • 4. What is the competitive strategic window for opportunities in the Global AI-based Clinical Trials Solution Provider Market?
  • 5. What are the technology trends and regulatory frameworks in the Global AI-based Clinical Trials Solution Provider Market?
  • 6. What is the market share of the leading vendors in the Global AI-based Clinical Trials Solution Provider Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global AI-based Clinical Trials Solution Provider Market?
Table of Contents
Product Code: MRR-035590448097

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Application Outlook
  • 3.4. End User Outlook
  • 3.5. Phase Outlook
  • 3.6. Region Outlook
  • 3.7. Competitor Outlook

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need for artificial Intelligence which helps in boosting and improving clinical trials
      • 5.1.1.2. Rising needs to reduce healthcare costs and declining hardware costs
      • 5.1.1.3. Increased adoption of AI-based drug development technology by most of the pharmaceutical companies
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of personal involvement leading to a rise in unemployment rates
      • 5.1.2.2. Possibility of a defective diagnosis
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements and innovations in AI-based clinical trials
      • 5.1.3.2. Major pharmaceutical companies are ensuring more joint ventures and partnerships with AI vendors
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with the adoption of EHR interoperability
  • 5.2. Porters Five Forces Analysis
    • 5.2.1. Threat of New Entrants
    • 5.2.2. Threat of Substitutes
    • 5.2.3. Bargaining Power of Customers
    • 5.2.4. Bargaining Power of Suppliers
    • 5.2.5. Industry Rivalry

6. AI-based Clinical Trials Solution Provider Market, by Application

  • 6.1. Introduction
  • 6.2. Cardiovascular Diseases
  • 6.3. Infectious Diseases
  • 6.4. Metabolic Diseases
  • 6.5. Neurological Diseases or Conditions
  • 6.6. Oncology

7. AI-based Clinical Trials Solution Provider Market, by End User

  • 7.1. Introduction
  • 7.2. Academia
  • 7.3. Others
  • 7.4. Pharmaceutical Companies

8. AI-based Clinical Trials Solution Provider Market, by Phase

  • 8.1. Introduction
  • 8.2. Phase-I
  • 8.3. Phase-II
  • 8.4. Phase-III

9. Americas AI-based Clinical Trials Solution Provider Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific AI-based Clinical Trials Solution Provider Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Thailand

11. Europe, Middle East & Africa AI-based Clinical Trials Solution Provider Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Key Player
  • 12.4. Competitive Scenario
    • 12.4.1. Merger & Acquisition
    • 12.4.2. Agreement, Collaboration, & Partnership
    • 12.4.3. New Product Launch & Enhancement
    • 12.4.4. Investment & Funding
    • 12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. AiCure, LLC
  • 13.2. Aiforia
  • 13.3. Antidote Technologies, Inc.
  • 13.4. Avantor, Inc.
  • 13.5. Deep 6 AI
  • 13.6. Deep Lens Inc.
  • 13.7. Innoplexus Consulting Services Pvt Ltd
  • 13.8. Intelligencia.ai
  • 13.9. MEDIAN Technologies
  • 13.10. Mendel.ai
  • 13.11. Pharmaceutical Pipeline Enhancement Strategies, LLC
  • 13.12. Saama Technologies Pvt Ltd
  • 13.13. Simplifai AS
  • 13.14. Trials.ai
  • 13.15. Unlearn.AI, Inc.

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY END USER, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY REGION, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 7. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: MARKET DYNAMICS
  • FIGURE 8. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 9. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 10. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 12. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY METABOLIC DISEASES, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY NEUROLOGICAL DISEASES OR CONDITIONS, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY NEUROLOGICAL DISEASES OR CONDITIONS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY ONCOLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY END USER, 2020 VS 2026 (%)
  • FIGURE 23. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY END USER, 2026
  • FIGURE 25. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY ACADEMIA, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY ACADEMIA, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY OTHERS, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY OTHERS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2026 (USD MILLION)
  • FIGURE 30. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE, 2020 VS 2026 (%)
  • FIGURE 32. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE, 2026
  • FIGURE 34. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE-I, 2018-2026 (USD MILLION)
  • FIGURE 35. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE-I, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 36. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE-II, 2018-2026 (USD MILLION)
  • FIGURE 37. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE-II, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 38. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE-III, 2018-2026 (USD MILLION)
  • FIGURE 39. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE-III, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 40. AMERICAS AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 41. ARGENTINA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 42. BRAZIL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 43. CANADA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 44. MEXICO AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 45. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 46. ASIA-PACIFIC AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 47. AUSTRALIA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 48. CHINA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 49. INDIA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 50. INDONESIA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 51. JAPAN AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 52. MALAYSIA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 53. PHILIPPINES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 54. SINGAPORE AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 55. SOUTH KOREA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 56. THAILAND AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 57. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 58. FRANCE AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 59. GERMANY AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 60. ITALY AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 61. NETHERLANDS AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 62. QATAR AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 63. RUSSIA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 64. SAUDI ARABIA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 65. SOUTH AFRICA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 66. SPAIN AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 67. UNITED ARAB EMIRATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 68. UNITED KINGDOM AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 69. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: FPNV POSITIONING MATRIX
  • FIGURE 70. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 71. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 4. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
  • TABLE 5. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 6. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 7. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 8. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY NEUROLOGICAL DISEASES OR CONDITIONS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 9. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 10. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
  • TABLE 11. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY ACADEMIA, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 12. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY OTHERS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 13. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 14. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE, 2018-2026 (USD MILLION)
  • TABLE 15. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE-I, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 16. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE-II, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 17. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE-III, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 18. AMERICAS AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 19. ARGENTINA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 20. BRAZIL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 21. CANADA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 22. MEXICO AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 23. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 24. ASIA-PACIFIC AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 25. AUSTRALIA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 26. CHINA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 27. INDIA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 28. INDONESIA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 29. JAPAN AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 30. MALAYSIA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 31. PHILIPPINES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 32. SINGAPORE AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 33. SOUTH KOREA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 34. THAILAND AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 35. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 36. FRANCE AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 37. GERMANY AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 38. ITALY AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 39. NETHERLANDS AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 40. QATAR AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 41. RUSSIA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 42. SAUDI ARABIA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 43. SOUTH AFRICA AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 44. SPAIN AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 45. UNITED ARAB EMIRATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 46. UNITED KINGDOM AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 47. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: SCORES
  • TABLE 48. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: BUSINESS STRATEGY
  • TABLE 49. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: PRODUCT SATISFACTION
  • TABLE 50. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: RANKING
  • TABLE 51. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 52. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: MERGER & ACQUISITION
  • TABLE 53. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 54. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 55. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: INVESTMENT & FUNDING
  • TABLE 56. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 57. GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: LICENSE & PRICING